TONIX PHARMACEUTICALS HOLDING CORP. Operating Lease Liability
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Operating Lease Liability of $1.27 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability $1.27M.
- 2026-03-31: Operating Lease, Liability $1.29M.
- 2025-12-31: Operating Lease, Liability $1.31M.
- 2025-09-30: Operating Lease, Liability $425.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.27M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.31M 10-K · filed 2026-03-12 |
| 2025-09-30 | $425.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $492.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $563.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $632.00K 10-K · filed 2025-03-18 |
| 2024-09-30 | $700.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $770.00K 10-Q · filed 2024-08-16 |
| 2024-03-31 | $840.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $902.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $1.15M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.27M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.03M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $760.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $886.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $985.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $802.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $956.00K 10-K · filed 2022-03-14 |
| 2021-09-30 | $1.11M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.05M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $963.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.31M 10-K · filed 2021-03-15 |
| 2020-09-30 | $1.21M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $441.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $281.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $358.00K 10-Q · filed 2020-05-12 |
| 2019-09-30 | $500.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $600.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $600.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |